Press release
Radiopharmaceuticals Market Size Forecasted To Achieve $10.59 Billion By 2029 With Steady Growth
Radiopharmaceuticals
How Big Is the Radiopharmaceuticals Market Size Expected to Be by 2034?
The radiopharmaceuticals market has shown steady growth, expected to rise from $6.46 billion in 2024 to $6.77 billion in 2025 at a CAGR of 4.7%. This expansion is attributed to increased healthcare spending, government initiatives, the convenience of treatment, and lifestyle changes.
The radiopharmaceuticals market is expected to grow rapidly, reaching $10.59 billion in 2029 with a CAGR of 11.8%. The growth is driven by the aging population, the increasing prevalence of cancer and heart disease, high investments, and new product innovations. Trends include company collaborations to boost revenue and product quality, expansion of plant capacities, AI-driven drug development, and innovations for cardiology treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3471
What Are the Emerging Segments Within the Radiopharmaceuticals Market?
The radiopharmaceuticals market covered in this report is segmented -
1) By Type: Diagnostic, Therapeutic
2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications
3) By End User: Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes
Subsegments:
1) By Diagnostic: Positron Emission Tomography (PET) Radiopharmaceuticals, Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
2) By Therapeutic: Alpha Emitters, Beta Emitters, Brachytherapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp
What Long-Term Drivers Are Shaping Radiopharmaceuticals Market Trends?
The radiopharmaceuticals market is anticipated to grow due to the increasing prevalence of cancer and cardiovascular diseases. Radiopharmaceuticals are emerging as an effective treatment option for these diseases, providing targeted therapies that offer advantages over conventional treatments. In April 2024, the International Agency for Research on Cancer (IARC) reported nearly 20 million new cancer cases in 2022, and the number is expected to increase to 29.9 million by 2040. This rising incidence of cancer and cardiovascular diseases is expected to drive the demand for radiopharmaceuticals.
Who Are the Top Competitors in Key Radiopharmaceuticals Market Segments?
Major companies operating in the radiopharmaceuticals market include Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, ÚJV Rež, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacýbaþý-Monrol Nuclear Products, NTP Radioisotopes.
What Trends Are Expected to Dominate the Radiopharmaceuticals Market in the Next 5 Years?
Companies in the radiopharmaceuticals market are increasingly opening new manufacturing plants and expanding production capacity. For instance, ITM Isotopen Technologien Munchen AG (ITM) launched a new facility in Munich to increase production of high-purity Lutetium-177, used in cancer treatment. This move helps the company meet global demand for quality medical isotopes used in precision oncology.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report
Which Regions Are Becoming Hubs for Radiopharmaceuticals Market Innovation?
The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Radiopharmaceuticals Market?
2. What is the CAGR expected in the Radiopharmaceuticals Market?
3. What Are the Key Innovations Transforming the Radiopharmaceuticals Industry?
4. Which Region Is Leading the Radiopharmaceuticals Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market Size Forecasted To Achieve $10.59 Billion By 2029 With Steady Growth here
News-ID: 4056947 • Views: …
More Releases from The Business Research Company
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward.
Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody…
Top Players and Competitive Dynamics in the Menopause Supplement Market
The menopause supplement market is set for significant expansion in the coming years, driven by evolving healthcare demands and growing awareness of women's wellness. As more individuals seek tailored health solutions, the market is responding with innovative products and services designed to support women during menopause and beyond. Below, we explore the market size, influential players, and emerging trends shaping this industry's future.
Expected Growth Trajectory of the Menopause Supplement Market
The…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The market for liquid carbon dioxide storage tanks is set for strong expansion in the coming years, supported by rising sustainability priorities and steady technological advancements across multiple industries. A closer look at the market size, major players, evolving trends, and detailed segmentation provides a clear understanding of the current dynamics and future potential.
Projected Growth and Market Size of Liquid Carbon Dioxide Storage Tanks
The liquid carbon dioxide storage tanks market…
Leading Companies Fueling Innovation and Growth in the Isotype Control Antibody …
The isotype control antibody market is set for significant expansion in the coming years, driven by advancements in medical research and technology. As laboratories and pharmaceutical companies increasingly adopt precision medicine, this sector is poised for rapid growth, reflecting broader trends in healthcare and biotechnology.
Anticipated Market Growth and Size for Isotype Control Antibodies
The market for isotype control antibodies is projected to reach $189.82 billion by 2029, growing at a robust…
More Releases for Radiopharmaceuticals
Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to…
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842
This latest report researches the industry structure, sales, revenue, price and…
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
